Morgan Stanley Maintains Overweight on Moelis, Lowers Price Target to $83

Benzinga Newsdesk www.benzinga.com Negative 60.3%

Neg 60.3% Neu 0% Pos 0%

Morgan Stanley analyst Ryan Kenny maintains Moelis (NYSE:MC) with a Overweight and lowers the price target from $90 to $83.